Maslak PG - Search Results

1

Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.

Rosenblat TL, McDevitt MR, Carrasquillo JA, Pandit-Taskar N, Frattini MG, Maslak PG, Park JH, Douer D, Cicic D, Larson SM, Scheinberg DA, Jurcic JG. Rosenblat TL, et al. Among authors: maslak pg. Clin Cancer Res. 2022 May 13;28(10):2030-2037. doi: 10.1158/1078-0432.CCR-21-3712. Clin Cancer Res. 2022. PMID: 35247915 Free PMC article. Clinical Trial.

2

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.

Jurcic JG, Caron PC, Miller WH Jr, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP Jr, Scheinberg DA. Jurcic JG, et al. Leukemia. 1995 Feb;9(2):244-8. Leukemia. 1995. PMID: 7869759

3

Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.

Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr. Vahdat L, et al. Blood. 1994 Dec 1;84(11):3843-9. Blood. 1994. PMID: 7949141 Free article. Review.

4

CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia.

Maslak P, Miller WH Jr, Heller G, Scheinberg DA, Dmitrovsky E, Warrell RP Jr. Maslak P, et al. Blood. 1993 Mar 15;81(6):1666. Blood. 1993. PMID: 8095829 Free article. No abstract available.

5

Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.

Maslak PG, Weiss MA, Berman E, Yao TJ, Tyson D, Golde DW, Scheinberg DA. Maslak PG, et al. Leukemia. 1996 Jan;10(1):32-9. Leukemia. 1996. PMID: 8558934 Clinical Trial.

6

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.

Weiss M, Maslak P, Feldman E, Berman E, Bertino J, Gee T, Megherian L, Seiter K, Scheinberg D, Golde D. Weiss M, et al. J Clin Oncol. 1996 Sep;14(9):2480-5. doi: 10.1200/JCO.1996.14.9.2480. J Clin Oncol. 1996. PMID: 8823326

7

A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia.

Weiss MA, Drullinsky P, Maslak P, Scheinberg D, Golde DW. Weiss MA, et al. Leukemia. 1998 Jun;12(6):865-8. doi: 10.1038/sj.leu.2401058. Leukemia. 1998. PMID: 9639412 Clinical Trial.

8

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr. Soignet SL, et al. N Engl J Med. 1998 Nov 5;339(19):1341-8. doi: 10.1056/NEJM199811053391901. N Engl J Med. 1998. PMID: 9801394 Free article.

9

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy.

Weiss MA, Glenn M, Maslak P, Rahman Z, Noy A, Zelenetz A, Scheinberg DA, Golde DW. Weiss MA, et al. Leukemia. 2000 Sep;14(9):1577-82. doi: 10.1038/sj.leu.2401892. Leukemia. 2000. PMID: 10995003 Clinical Trial.

10

Targeted therapies for the myeloid leukaemias.

Maslak P, Scheinberg D. Maslak P, et al. Expert Opin Investig Drugs. 2000 Jun;9(6):1197-205. doi: 10.1517/13543784.9.6.1197. Expert Opin Investig Drugs. 2000. PMID: 11060736 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page